Business Description
Coiled Therapeutics PLC
ISIN : GB00BSHRN331
Total Employee Number:
1Description
Coiled Therapeutics PLC principal activity of the Company is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -11.5 | |||||
3-Year EPS without NRI Growth Rate | 28.9 | |||||
3-Year FCF Growth Rate | 34.9 | |||||
3-Year Book Growth Rate | -35.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 76.34 | |||||
9-Day RSI | 61.97 | |||||
14-Day RSI | 57.94 | |||||
3-1 Month Momentum % | -4.31 | |||||
6-1 Month Momentum % | -31.87 | |||||
12-1 Month Momentum % | -70.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.43 | |||||
Quick Ratio | 0.43 | |||||
Cash Ratio | 0.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.2 | |||||
Shareholder Yield % | -0.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -83.62 | |||||
ROA % | -71.5 | |||||
ROIC % | -17.39 | |||||
3-Year ROIIC % | -28.26 | |||||
ROC (Joel Greenblatt) % | -688.81 | |||||
ROCE % | -79.98 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.73 | |||||
EV-to-EBIT | -12.5 | |||||
EV-to-EBITDA | -12.51 | |||||
EV-to-FCF | -64.77 | |||||
Earnings Yield (Greenblatt) % | -8 | |||||
FCF Yield % | -1.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:COTXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coiled Therapeutics PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.294 | ||
| Beta | 0.6139 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 67.66 | ||
| 14-Day RSI | 57.94 | ||
| 14-Day ATR ($) | 0.004988 | ||
| 20-Day SMA ($) | 0.142083 | ||
| 12-1 Month Momentum % | -70.91 | ||
| 52-Week Range ($) | 0.0964 - 0.5 | ||
| Shares Outstanding (Mil) | 426.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coiled Therapeutics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coiled Therapeutics PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-09-30 | In 98 days | ||
| General meeting for 2025 | 2026-06-24 09:00 | In 1 day | ||
| Annual report for 2025 | 2026-05-06 | 0.10 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-05-06 | 0.10 (+0.00%) | ||
| 0.1:1 Stock Split | 2026-03-27 | 0.15 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-09-30 | 0.21 (+0.00%) | ||
| General meeting for 2024 | 2025-06-26 10:00 | 0.50 (+0.00%) | ||
| Annual report for 2024 | 2025-04-30 | 0.50 (+0.00%) | ||
| Fourth quarter earnings results for 2024 | 2025-04-30 | 0.50 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-09-27 | 0.49 (+0.00%) |
Show
Entries
Coiled Therapeutics PLC Frequently Asked Questions
What is Coiled Therapeutics PLC(COTXF)'s stock price today?
The current price of COTXF is $0.14. The 52 week high of COTXF is $0.50 and 52 week low is $0.10.
When is next earnings date of Coiled Therapeutics PLC(COTXF)?
The next earnings date of Coiled Therapeutics PLC(COTXF) is 2026-09-30 Est..
Does Coiled Therapeutics PLC(COTXF) pay dividends? If so, how much?
Coiled Therapeutics PLC(COTXF) does not pay dividend.
Guru Commentaries on OTCPK:COTXF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Coiled Therapeutics PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers